blinatumomab
Showing 1 - 25 of 59
Immune Reconstitution After Allo-HSCT and Blinatumomab
Not yet recruiting
- Leukemia, Lymphoid
- blinatumomab
- (no location specified)
Oct 3, 2023
Leukemia, Lymphoid Trial in Chengdu (blinatumomab)
Recruiting
- Leukemia, Lymphoid
- blinatumomab
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 27, 2023
Leukemia, Lymphoid Trial in Chengdu (blinatumomab)
Not yet recruiting
- Leukemia, Lymphoid
- blinatumomab
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 3, 2023
B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)
Not yet recruiting
- B Precursor Acute Lymphoblastic Leukemia
- Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
- Blinatumomab
- (no location specified)
Sep 25, 2023
Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)
Recruiting
- Acute Lymphoblastic Leukemia
- Blinatumomab
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023
Next-generation Sequencing in Pediatric B-ALL Children Patients
Not yet recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Blinatumomab
- (no location specified)
Apr 19, 2023
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2022
B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)
Recruiting
- B Acute Lymphoblastic Leukemia
- Blinatumomab
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022
Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)
Recruiting
- Acute Lymphoblastic Leukemia
- Philadelphia Chromosome-Positive
- Blinatumomab
- +3 more
-
New York, New York
- +1 more
Nov 10, 2022
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Blinatumomab
- Conventional therapy
-
Suzhou, Jiangsu, ChinaThe first affiliated hospital of Soochow University
Sep 26, 2022
Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)
Completed
- Hematopoietic/Lymphoid Cancer
- Richter's Transformation
- Blinatumomab
- Dexamethasone
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2022
B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Blinatumomab
-
Milwaukee, WisconsinMedical College of Wisconsin
Apr 4, 2022
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Blinatumomab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
May 4, 2022
B-Precursor ALL Trial in Germany (Blinatumomab)
Recruiting
- B-Precursor ALL
- Blinatumomab
-
Frankfurt (Main), Hessen, Germany
- +20 more
Aug 16, 2022
B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)
Terminated
- B-Cell Acute Lymphoblastic Leukemia, Adult
- blinatumomab
- pembrolizumab
-
La Jolla, California
- +2 more
Apr 26, 2022
Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)
Active, not recruiting
- Lymphoblastic Leukemia, Acute, Adult
- +2 more
- Blinatumomab
-
Brno, Czechia
- +4 more
Aug 3, 2022
Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)
Completed
- Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
- Blinatumomab
-
Nagoya-shi, Aichi, Japan
- +15 more
Dec 8, 2022
Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)
Completed
- Relapsed/Refractory Philadelphia Positive B-precursor ALL
- Blinatumomab
-
Duarte, California
- +21 more
Sep 8, 2022
Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Mixed Phenotype Acute Leukemia
- Blinatumomab
- (no location specified)
Apr 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)
Recruiting
- ALL, Recurrent, Adult
- Blinatumomab
- Venetoclax
-
Frankfurt (Main), Hessen, Germany
- +1 more
Jan 6, 2022
ALL, Recurrent, Adult Trial in Germany (Blinatumomab)
Active, not recruiting
- ALL, Recurrent, Adult
- Blinatumomab
-
Frankfurt (Main), Hessen, Germany
- +21 more
Mar 16, 2022